ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 844–851
DOI: 10.46882/AJIDR/149023
Article Type: Research Article
Title: Clinical spectrum, diagnostic biomarkers, and echinocandin outcomes in Pneumocystis jirovecii pneumonia among non-HIV immunosuppressed adults
Names of Authors: Rohan Patel¹*, Naledi Khumalo², Stefan Weber³
Abstract: Pneumocystis jirovecii pneumonia increasingly affects patients receiving immunosuppressive biologics, chemotherapy, or solid organ transplants, often presenting with fulminant hypoxemic respiratory failure. We evaluated serum beta-D-glucan diagnostic accuracy, fungal burden, and clinical outcomes in non-HIV immunocompromised patients. Bronchoalveolar lavage fluid and serum specimens from 124 suspected patients were analyzed via quantitative polymerase chain reaction and colorimetric beta-D-glucan assays. Combining serum beta-D-glucan above 200 picograms per milliliter with quantitative polymerase chain reaction achieved 94.2 percent diagnostic specificity. Prompt trimethoprim-sulfamethoxazole therapy alongside adjunctive corticosteroids improves survival.
Keywords: Pneumocystis jirovecii, Opportunistic pneumonia, Beta-D-glucan, Immunosuppression, Fungal diagnostics
Citation: Patel R, Khumalo N, Weber S (2026). Clinical spectrum, diagnostic biomarkers, and echinocandin outcomes in Pneumocystis jirovecii pneumonia among non-HIV immunosuppressed adults. African Journal of Infectious Diseases Research, 13(11): 844–851. DOI: 10.46882/AJIDR/149023
Manuscript Timeline: Received: September 28, 2026; Revised: October 29, 2026; Accepted: November 20, 2026; Published: November 28, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read